GlaxoSmithKline PLC Director/PDMR Shareholding (9187W)
April 29 2016 - 12:43PM
UK Regulatory
TIDMGSK
RNS Number : 9187W
GlaxoSmithKline PLC
29 April 2016
GlaxoSmithKline plc
Notification of Transactions of Directors, Persons
Discharging
Managerial Responsibilities or Connected Persons
The Administrators of the GlaxoSmithKline 2009 Performance Share
Plan (the 'Plan') notified GlaxoSmithKline plc ('GSK') on 28 April
2016 that the under-mentioned Directors, Persons Discharging
Managerial Responsibilities ('PDMR') and Connected Persons acquired
notional Ordinary Shares at a price of 1502.00 pence per Ordinary
Share and American Depositary Shares ('ADSs') at a price of $42.64
per ADS, following the notional re-investment of the dividend paid
to shareholders on 14 April 2016.
Director/PDMR Ordinary ADSs
Shares
------------------- ----------- -----------
Sir Andrew Witty 41,688.082
------------------- ----------- -----------
Dr M M Slaoui 12,095.870
------------------- ----------- -----------
Mr S Dingemans 17,503.320
------------------- ----------- -----------
Mr R G Connor 8,568.501
------------------- ----------- -----------
Mr N Hirons 2,666.231 215.628
------------------- ----------- -----------
Mr S A Hussain 17,903.405
------------------- ----------- -----------
Mr D S Redfern 6,379.260
------------------- ----------- -----------
Ms C Thomas 8,495.290
------------------- ----------- -----------
Mr P C Thomson 4,638.016
------------------- ----------- -----------
Mr D E Troy 7,534.332
------------------- ----------- -----------
Dr P J T Vallance 18,629.480
------------------- ----------- -----------
Ms E Walmsley 14,203.165
------------------- ----------- -----------
Mrs V A Whyte 1,072.219
------------------- ----------- -----------
Connected Person Ordinary ADSs
Shares
------------------------ ------------ --------
Dr K Slaoui (Connected
Person to Dr M
M Slaoui) 184.627
-------------------------------------- --------
The notional dividends accrued will be paid out in proportion to
the percentage of participants' Plan holdings that vest following
the end of the relevant measurement period.
This notification relates to transactions notified in accordance
with Disclosure and Transparency Rule 3.1.4R(1)(a) and (c).
V A Whyte
Company Secretary
29 April 2016
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHQKLFLQZFZBBL
(END) Dow Jones Newswires
April 29, 2016 12:43 ET (16:43 GMT)
Gsk (LSE:GSK)
Historical Stock Chart
From Aug 2024 to Sep 2024
Gsk (LSE:GSK)
Historical Stock Chart
From Sep 2023 to Sep 2024